Efficacy of JAK inhibitors in treating dominant dystrophic epidermolysis bullosa and alopecia areata

Affiliations

¹ Dermatology Clinic, Istituto Dermopatico dell'Immacolata (IDI)-IRCCS, Rome, Italy - f.moro@idi.it.
² Laboratory of Molecular and Cell Biology, Istituto Dermopatico dell'Immacolata (IDI)-IRCCS, Rome, Italy - f.moro@idi.it.
³ Clinical Epidemiology Unit, Istituto Dermopatico dell'Immacolata (IDI)-IRCCS, Rome, Italy.
⁴ Dermatology Clinic, Istituto Dermopatico dell'Immacolata (IDI)-IRCCS, Rome, Italy.
⁵ Laboratory of Molecular and Cell Biology, Istituto Dermopatico dell'Immacolata (IDI)-IRCCS, Rome, Italy.
⁶ Rare Skin Disease Center, Istituto Dermopatico dell'Immacolata (IDI)-IRCCS, Rome, Italy.

Francesco Moro et al. Ital J Dermatol Venerol. 2025.

. 2025 Oct 3.

doi: 10.23736/S2784-8671.25.08236-2. Online ahead of print.

¹ Dermatology Clinic, Istituto Dermopatico dell'Immacolata (IDI)-IRCCS, Rome, Italy - f.moro@idi.it.
² Laboratory of Molecular and Cell Biology, Istituto Dermopatico dell'Immacolata (IDI)-IRCCS, Rome, Italy - f.moro@idi.it.
³ Clinical Epidemiology Unit, Istituto Dermopatico dell'Immacolata (IDI)-IRCCS, Rome, Italy.
⁴ Dermatology Clinic, Istituto Dermopatico dell'Immacolata (IDI)-IRCCS, Rome, Italy.
⁵ Laboratory of Molecular and Cell Biology, Istituto Dermopatico dell'Immacolata (IDI)-IRCCS, Rome, Italy.
⁶ Rare Skin Disease Center, Istituto Dermopatico dell'Immacolata (IDI)-IRCCS, Rome, Italy.

No abstract available

LinkOut - more resources